Literature DB >> 6989221

Captopril in severe treatment-resistant hypertension.

R K Ferguson, P H Vlasses, J R Koplin, A Shirinian, J F Burke, J C Alexander.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6989221     DOI： 10.1016/0002-8703(80)90730-9

Source DB:  PubMed          Journal:  Am Heart J        ISSN： 0002-8703            Impact factor:   4.749


× No keyword cloud information.
  11 in total

Review 1.  Hypertensive emergencies and urgencies: definition, recognition, and management.

Authors:  J B Reuler; G J Magarian
Journal:  J Gen Intern Med       Date:  1988 Jan-Feb       Impact factor: 5.128

2.  Angiotensin-converting enzyme inhibitors in the treatment of hypertension.

Authors:  C I Johnston; L Arnolda; M Hiwatari
Journal:  Drugs       Date:  1984-03       Impact factor: 9.546

3.  Long-term experience with captopril in severe hypertension.

Authors:  J Havelka; H J Boerlin; A Studer; P Greminger; W Tenschert; T Luescher; W Siegenthaler; W Vetter; P Walger; H Vetter
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

4.  [Results of a 5-year study with captopril in patients with severe therapy-resistant hypertension].

Authors:  J Schrader; G Schoel; F Scheler
Journal:  Klin Wochenschr       Date:  1986-08-01

Review 5.  Adverse reactions with angiotensin converting enzyme (ACE) inhibitors.

Authors:  R DiBianco
Journal:  Med Toxicol       Date:  1986 Mar-Apr

6.  Captopril as treatment for patients with pulmonary hypertension. Problem of variability in assessing chronic drug treatment.

Authors:  S Rich; J Martinez; W Lam; K M Rosen
Journal:  Br Heart J       Date:  1982-09

Review 7.  Captopril: a preliminary review of its pharmacological properties and therapeutic efficacy.

Authors:  R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1980-12       Impact factor: 9.546

8.  Captopril for refractory hypertension in patients with impaired renal function.

Authors:  M S Laher; P O'Regan; J F O'Donohoe; T B Counihan
Journal:  J R Soc Med       Date:  1985-05       Impact factor: 5.344

9.  Hypertension: an update.

Authors:  E S Cooper
Journal:  J Natl Med Assoc       Date:  1982-05       Impact factor: 1.798

10.  Effects of the converting enzyme inhibitor captopril on blood coagulation and fibrinolysis in man.

Authors:  J Schrader; H Köstering; H J Gröne; E J Kirchertz; F Scheler
Journal:  Klin Wochenschr       Date:  1982-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.